76 related articles for article (PubMed ID: 15026413)
1. Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.
Hashimoto M; Bar-On P; Ho G; Takenouchi T; Rockenstein E; Crews L; Masliah E
J Biol Chem; 2004 May; 279(22):23622-9. PubMed ID: 15026413
[TBL] [Abstract][Full Text] [Related]
2. Synuclein Proteins in Cancer Development and Progression.
Zanotti LC; Malizia F; Cesatti Laluce N; Avila A; Mamberto M; Anselmino LE; Menacho-Márquez M
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371560
[TBL] [Abstract][Full Text] [Related]
3. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.
Fazzari M; Di Biase E; Zaccagnini L; Henriques A; Callizot N; Ciampa MG; Mauri L; Carsana EV; Loberto N; Aureli M; Mari L; Civera M; Vasile F; Sonnino S; Bartels T; Chiricozzi E; Lunghi G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159350. PubMed ID: 37330108
[TBL] [Abstract][Full Text] [Related]
4. Intragenic β-synuclein rearrangements in malignancy.
Xiao P; Chen N; Shao T; Bian X; Miao J; Zheng J; Lang X; Wang Y; Chen X; Jin L; Hu S; Xiao S
Front Oncol; 2023; 13():1167143. PubMed ID: 37251917
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy.
Wei J; Ho G; Masliah E; Hashimoto M
Prion; 2023 Dec; 17(1):29-34. PubMed ID: 36785484
[TBL] [Abstract][Full Text] [Related]
6. Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons.
Goloborshcheva VV; Kucheryanu VG; Voronina NA; Teterina EV; Ustyugov AA; Morozov SG
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140378
[TBL] [Abstract][Full Text] [Related]
7. Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.
Carnazza KE; Komer LE; Xie YX; Pineda A; Briano JA; Gao V; Na Y; Ramlall T; Buchman VL; Eliezer D; Sharma M; Burré J
Cell Rep; 2022 Apr; 39(2):110675. PubMed ID: 35417693
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Akt/PKB Kinase Increases Na
Marosi M; Nenov MN; Di Re J; Dvorak NM; Alshammari M; Laezza F
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163623
[TBL] [Abstract][Full Text] [Related]
9. β-Synuclein: An Enigmatic Protein with Diverse Functionality.
Hayashi J; Carver JA
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053291
[TBL] [Abstract][Full Text] [Related]
10. No Association Between AKT1 Polymorphisms and Methamphetamine Addiction in Iranian Population.
Ghafouri-Fard S; Azari I; Hashemian F; Nejatizadeh A; Taheri M
J Mol Neurosci; 2020 Mar; 70(3):303-307. PubMed ID: 31654273
[TBL] [Abstract][Full Text] [Related]
11. The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.
Rai SN; Dilnashin H; Birla H; Singh SS; Zahra W; Rathore AS; Singh BK; Singh SP
Neurotox Res; 2019 Apr; 35(3):775-795. PubMed ID: 30707354
[TBL] [Abstract][Full Text] [Related]
12. Target Proteins in the Dorsal Hippocampal Formation Sustain the Memory-Enhancing and Neuroprotective Effects of
Gaiardo RB; Abreu TF; Tashima AK; Telles MM; Cerutti SM
Front Pharmacol; 2018; 9():1533. PubMed ID: 30666208
[TBL] [Abstract][Full Text] [Related]
13. Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy.
Sargent D; Bétemps D; Drouyer M; Verchere J; Gaillard D; Arsac JN; Lakhdar L; Salvetti A; Baron T
Sci Rep; 2018 Dec; 8(1):17563. PubMed ID: 30510219
[TBL] [Abstract][Full Text] [Related]
14. 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both
Hu J; Ferchmin PA; Hemmerle AM; Seroogy KB; Eterovic VA; Hao J
Front Neurosci; 2017; 11():272. PubMed ID: 28611572
[TBL] [Abstract][Full Text] [Related]
15. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
[TBL] [Abstract][Full Text] [Related]
16. Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation.
Ma Z; Niu J; Sun E; Rong X; Zhang X; Ju Y
Tumour Biol; 2016 Nov; 37(11):14999-15005. PubMed ID: 27655287
[TBL] [Abstract][Full Text] [Related]
17. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
Janowska MK; Wu KP; Baum J
Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
[TBL] [Abstract][Full Text] [Related]
18. Association between AKT1 Gene Polymorphism rs2498794 and Smoking-Related Traits with reference to Cancer Susceptibility.
Nishizawa D; Kasai S; Hasegawa J; Sato N; Tanioka F; Sugimura H; Ikeda K; Dobashi Y
Biomed Res Int; 2015; 2015():316829. PubMed ID: 26137473
[TBL] [Abstract][Full Text] [Related]
19. Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats.
Böhm MR; Melkonyan H; Thanos S
Front Neuroanat; 2015; 9():16. PubMed ID: 25788877
[TBL] [Abstract][Full Text] [Related]
20. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
